Combination therapy in HBeAg-negative chronic hepatitis B patients with low-level viremia to nucleos (tide) analogues

被引：0
作者：
Chen, Xin-Yue [1 ,2 ]
Ren, Shan [1 ,2 ]
Lu, Junfeng [2 ]
Ma, Lina [2 ]
Zheng, Sujun [2 ]
Hu, Zhongjie [2 ]
机构：
[1] Capital Med Univ, Beijing Youan Hosp, Beijing, Peoples R China
[2] Capital Med Univ, Beijing Youan Hosp, Dept Liver Dis 1, Beijing, Peoples R China
来源：
JOURNAL OF HEPATOLOGY | 2022年 / 77卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT382
引用
收藏
页码：S844 / S844
页数：1
相关论文
共 50 条
[21]   Impaired intrahepatic hepatitis B virus productivity contributes to low viremia in most HBeAg-negative patients [J].
Volz, Tassilo ;
Lutgehetmann, Marc ;
Wachtler, Paul ;
Jacob, Anna ;
Quaas, Alexander ;
Murray, John M. ;
Dandri, Maura ;
Petersen, Joerg .
GASTROENTEROLOGY, 2007, 133 (03) :843-852
[22]   Stopping long-term treatment with nucleos(t)ide analogues is a favourable option for selected patients with HBeAg-negative chronic hepatitis B [J].
van Boemmel, Florian ;
Berg, Thomas .
LIVER INTERNATIONAL, 2018, 38 :90-96
[23]   Treatment of HBeAg-negative chronic hepatitis B patients with nucleos(t)ide analogues (vol 31, pg e95, 2011) [J].
Papatheodoridis, G., V .
LIVER INTERNATIONAL, 2011, 31 (05) :748-748
[24]   Real-world study on HBsAg loss of combination therapy in HBeAg-negative chronic hepatitis B patients [J].
Chu, Jun-Hao ;
Huang, Yan ;
Xie, Dong-Ying ;
Deng, Hong ;
Wei, Jia ;
Guan, Yu-Juan ;
Li, Guo-Jun ;
Zeng, Yi-Lan ;
Yang, Jia-Hong ;
Chen, Xin-Yue ;
Shang, Jia ;
Li, Jia-Bin ;
Gao, Na ;
Gao, Zhi-Liang .
JOURNAL OF VIRAL HEPATITIS, 2022, 29 (09) :765-776
[25]   Discontinuation of Nucleos(t)ide Analogues in HBeAg Negative Chronic Hepatitis B Patients: Risks and Benefits [J].
Korkmaz, Pinar ;
Demirtuerk, Nese .
INFECTIOUS DISEASES AND CLINICAL MICROBIOLOGY, 2024, 6 (02) :70-77
[26]   Quantitative DNA analysis of low-level hepatitis B viremia in two patients with serologically negative chronic hepatitis B [J].
Saito, T ;
Shinzawa, H ;
Uchida, T ;
Kawamata, O ;
Honma, S ;
Watanabe, H ;
Shao, L ;
Saito, K ;
Togashi, H ;
Takahashi, T .
JOURNAL OF MEDICAL VIROLOGY, 1999, 58 (04) :325-331
[27]   Antiviral therapy leads to histological improvement of HBeAg-negative chronic hepatitis B patients [J].
Papachrysos, Nikolaos ;
Hytiroglou, Prodromos ;
Papalavrentios, Lavrentios ;
Sinakos, Emmanouil ;
Kouvelis, Ioannis ;
Akriviadis, Evangelos .
ANNALS OF GASTROENTEROLOGY, 2015, 28 (03) :374-378
[28]   The main reasons for finite Nuc therapy in HBeAg-negative chronic hepatitis B patients [J].
Peng, Chien-Wei ;
Jeng, Wen-Juei .
HEPATOLOGY INTERNATIONAL, 2021, 15 (02) :527-528
[29]   Antiviral therapy leads to histological improvement in HBeAg-negative chronic hepatitis B patients [J].
Basyigit, Sebahat ;
Sapmaz, Ferdane ;
Yeniova, Abdullah O. .
ANNALS OF GASTROENTEROLOGY, 2015, 28 (04) :506-+
[30]   The main reasons for finite Nuc therapy in HBeAg-negative chronic hepatitis B patients [J].
Chien-Wei Peng ;
Wen-Juei Jeng .
Hepatology International, 2021, 15 :527-528
12345